Jazz Pharmaceuticals, Inc.
3180 Porter Drive
Palo Alto,
CA 94304
United States - Map
Phone: 650-496-3777
Fax: 650-496-3781
Web Site: http://www.jazzpharmaceuticals.com
| Jazz Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes products for neurology and psychiatry primarily in the United States. The companys marketed products include Xyrem for the treatment of excessive daytime sleepiness and cataplexy in patients with narcolepsy; and Luvox CR for obsessive compulsive disorder and social anxiety disorder. Its product candidate in Phase III clinical trials comprise JZP-6 for the treatment of fibromyalgia. The companys other product candidates in clinical development comprises JZP-8, an intranasal formulation of clonazepam for the treatment of recurrent acute repetitive seizures in epilepsy patients who continue to have seizures while on stable anti-epileptic regimens; JZP-4, a controlled release formulation of an anticonvulsant for the treatment of epilepsy and bipolar disorder; and JZP-7 for the treatment of restless legs syndrome. Jazz Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Palo Alto, California. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Bruce C. Cozadd , 45
Co-Founder, Exec. Chairman and Chief Exec. Officer |
$
423.00K |
$
0 | Mr. Robert M. Myers , 45
Co-Founder, Pres |
$
444.00K |
$
0 | Dr. Samuel R. Saks M.D.,
Co-Founder and Consultant |
$
468.00K |
$
0 | Ms. Carol A. Gamble Esq., 57
Sr. VP, Sec. and Gen. Counsel |
$
357.00K |
$
0 | Ms. Joan E. Colligan , 58
Acting Principal Financial Officer, Principal Accounting Officer and Controller |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
1.48% Nasdaq 
Profile
